Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Defective Autophagy in Atherosclerosis: To Die or to Senesce?
Mandy O. J. Grootaert, Lynn Roth, D. Schrijvers, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Mitochondrial and metabolic dysfunction in ageing and age-related diseases
João A. Amorim, Giuseppe Coppotelli, Anabela P. Rolo, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 4, pp. 243-258
Open Access | Times Cited: 567
Role of lysosomes in physiological activities, diseases, and therapy
Ziqi Zhang, Pengfei Yue, Tianqi Lu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 214
Macrophage Death as a Pharmacological Target in Atherosclerosis
Wim Martinet, Isabelle Coornaert, Pauline Puylaert, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 190
Mitophagy in Human Diseases
Laura Doblado, Claudia Lueck, Claudia Rey, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3903-3903
Open Access | Times Cited: 168
Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms
Yuzhou Gui, Hongchao Zheng, Richard Y. Cao
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 146
Inflammation in atherosclerosis: pathophysiology and mechanisms
Amir Ajoolabady, Domenico Praticò, Ling Lin, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access | Times Cited: 24
Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease
María Camacho Encina, Laura Booth, Rachael Redgrave, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 353-353
Open Access | Times Cited: 22
Traditional Chinese medicine and mitophagy: A novel approach for cardiovascular disease management
Jinhui Wang, Junbo Zou, Yajun Shi, et al.
Phytomedicine (2024) Vol. 128, pp. 155472-155472
Closed Access | Times Cited: 21
Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
Stevan D. Stojanović, Jan Fiedler, Johann Bauersachs, et al.
European Heart Journal (2019) Vol. 41, Iss. 31, pp. 2983-2996
Open Access | Times Cited: 143
PINK1/Parkin‐mediated mitophagy promotes apelin‐13‐induced vascular smooth muscle cell proliferation by AMPKα and exacerbates atherosclerotic lesions
Lu He, Qionglin Zhou, Zheng Huang, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 6, pp. 8668-8682
Closed Access | Times Cited: 108
Long noncoding RNA p21 enhances autophagy to alleviate endothelial progenitor cells damage and promote endothelial repair in hypertension through SESN2/AMPK/TSC2 pathway
Chao Li, Lin Lin, Lei Zhang, et al.
Pharmacological Research (2021) Vol. 173, pp. 105920-105920
Open Access | Times Cited: 101
Mitochondrial quality control in acute ischemic stroke
Hong An, Bing Zhou, Xunming Ji
Journal of Cerebral Blood Flow & Metabolism (2021) Vol. 41, Iss. 12, pp. 3157-3170
Open Access | Times Cited: 76
Accelerated Kidney Aging in Diabetes Mellitus
Jing Guo, Huijuan Zheng, Wenting Zhang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-24
Open Access | Times Cited: 75
Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation
Ewa Wojtaszek, Urszula Ołdakowska‐Jedynak, Marlena Kwiatkowska, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 63
Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation
Hongxia Li, Zhiqiang Cao, Lili Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 59
Autophagy Is Differentially Regulated in Leukocyte and Nonleukocyte Foam Cells During Atherosclerosis
Sabrina Robichaud, Adil Rasheed, Antonietta Pietrangelo, et al.
Circulation Research (2022) Vol. 130, Iss. 6, pp. 831-847
Open Access | Times Cited: 52
Melatonin inhibits atherosclerosis progression via galectin‐3 downregulation to enhance autophagy and inhibit inflammation
Zitong Wang, Ziyu Gao, Yinghong Zheng, et al.
Journal of Pineal Research (2023) Vol. 74, Iss. 3
Open Access | Times Cited: 36
The role of autophagy in cardiovascular disease: Cross-interference of signaling pathways and underlying therapeutic targets
Bing Jiang, Xuan Zhou, Tao Yang, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 36
Mitochondrial Melatonin: Beneficial Effects in Protecting against Heart Failure
Rüssel J. Reiter, Ramaswamy Sharma, Luiz Gustavo de Almeida Chuffa, et al.
Life (2024) Vol. 14, Iss. 1, pp. 88-88
Open Access | Times Cited: 10
Mitochondrial Dysfunction and DNA Damage in the Context of Pathogenesis of Atherosclerosis
Taisiia S. Shemiakova, Ekaterina A. Ivanova, Andrey V. Grechko, et al.
Biomedicines (2020) Vol. 8, Iss. 6, pp. 166-166
Open Access | Times Cited: 69
Atherosclerosis Treatment with Stimuli‐Responsive Nanoagents: Recent Advances and Future Perspectives
Ali Maruf, Yi Wang, Tieyin Yin, et al.
Advanced Healthcare Materials (2019) Vol. 8, Iss. 11
Open Access | Times Cited: 66
Vascular autophagy in health and disease
William E. Hughes, Andreas Beyer, David D. Gutterman
Basic Research in Cardiology (2020) Vol. 115, Iss. 4
Closed Access | Times Cited: 64
Role of Mitophagy in Cardiovascular Disease
Yibo Yang, Tianyi Li, Zhibo Li, et al.
Aging and Disease (2020) Vol. 11, Iss. 2, pp. 419-419
Open Access | Times Cited: 59
Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application
Yandong Liu, Futang Yang, Sili Zou, et al.
Frontiers in Pharmacology (2019) Vol. 9
Open Access | Times Cited: 58
Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation
Alexander N. Orekhov, Anastasia V. Poznyak, Igor A. Sobenin, et al.
Current Neuropharmacology (2019) Vol. 18, Iss. 11, pp. 1064-1075
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top